600587.SS · 新华医疗
China A-shares · RS rating 66 · As of 2026-10-14
| Price | 12.54 CNY |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 66 / 74 / 63 / 36 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 24 / 24 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +29.0% |
| Distance from 52-week high | +26.1% |
| Market cap (USD) | $1.2B |